Free Trial

Joint (JYNT) Stock Price, News & Analysis

Joint logo
$6.91 +0.01 (+0.14%)
Closing price 04:00 PM Eastern
Extended Trading
$6.91 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Joint Stock (NASDAQ:JYNT)

Advanced

Key Stats

Today's Range
$6.85
▼
$7.04
50-Day Range
$6.90
▼
$8.68
52-Week Range
$6.79
▼
$10.67
Volume
60,710 shs
Average Volume
82,317 shs
Market Capitalization
$97.73 million
P/E Ratio
25.59
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

The Joint Corp. operates The Joint Chiropractic, a network of chiropractic clinics that provides convenient, primarily cash-based chiropractic care. Its services generally include chiropractic consultations, examinations and adjustments intended to support musculoskeletal health and wellness.

The company’s business model combines company-owned clinics with franchised locations. Clinics commonly offer membership and wellness plans, as well as individual visits, giving customers access to recurring chiropractic care without relying primarily on traditional insurance arrangements. Franchisees operate their clinics under The Joint Chiropractic brand and use the company’s operating systems, marketing support and service model.

Founded in 1999, The Joint Corp. is headquartered in Scottsdale, Arizona, and serves customers through clinics across the United States. The company is listed on the Nasdaq under the symbol JYNT.

AI Generated. May Contain Errors.

Joint Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
48th Percentile Overall Score

JYNT MarketRank™: 
2.38502743663 of 5 stars

Joint scored higher than 48% of companies evaluated by MarketBeat, and ranked 631st out of 870 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Joint has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Joint has only been the subject of 1 research reports in the past 90 days.

  • Read more about Joint's stock forecast and price target.
  • Earnings Growth

    Earnings for Joint are expected to grow by 116.13% in the coming year, from $0.31 to $0.67 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Joint is 25.59, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.86.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Joint is 25.59, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.96.

  • Price to Book Value per Share Ratio

    Joint has a P/B Ratio of 6.84. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Joint's valuation and earnings.
  • Percentage of Shares Shorted

    4.11% of the float of Joint has been sold short.
  • Short Interest Ratio / Days to Cover

    Joint has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Joint has recently decreased by 7.71%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Joint does not currently pay a dividend.

  • Dividend Growth

    Joint does not have a long track record of dividend growth.

  • News Sentiment

    Joint has a news sentiment score of 1.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Joint this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Joint insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    30.20% of the stock of Joint is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    76.88% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Joint's insider trading history.
Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

JYNT Stock News Headlines

Joint Reacquires Regional Developer Rights Across Texas
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel
The Joint Corp.(NasdaqCM:JYNT) dropped from S&P Global BMI Index
The Joint Corp. (JYNT) Q2 2026 Earnings Call Transcript
See More Headlines

JYNT Stock Analysis - Frequently Asked Questions

Joint's stock was trading at $8.72 on January 1st, 2026. Since then, JYNT stock has decreased by 20.8% and is now trading at $6.91.

The Joint Corp. (NASDAQ:JYNT) released its quarterly earnings data on Thursday, August, 6th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.00. The company earned $15.18 million during the quarter, compared to analysts' expectations of $14.57 million. Joint had a net margin of 6.49% and a trailing twelve-month return on equity of 12.02%.
Read the conference call transcript
.

Joint's board approved a stock repurchase program on Thursday, June 5th 2025, which allows the company to repurchase $5,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 2.7% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's management believes its shares are undervalued.

Joint (JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at a price of $6.00-$7.00 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Joint investors own include NVIDIA (NVDA), Tesla (TSLA), Salesforce (CRM), InMode (INMD), Micron Technology (MU), Advanced Micro Devices (AMD) and Intuit (INTU).

Company Calendar

Last Earnings
8/06/2026
Today
10/15/2026
Next Earnings (Estimated)
11/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:JYNT
CIK
1612630
Employees
330
Year Founded
1999

Profitability

EPS (Trailing Twelve Months)
$0.27
Trailing P/E Ratio
25.59
Forward P/E Ratio
22.29
P/E Growth
N/A
Net Income
$2.91 million
Net Margins
6.49%
Pretax Margin
3.61%
Return on Equity
12.02%
Return on Assets
3.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.83
Quick Ratio
1.83

Sales & Book Value

Annual Sales
$58.55 million
Price / Sales
1.67
Cash Flow
$0.10 per share
Price / Cash Flow
71.71
Book Value
$1.01 per share
Price / Book
6.84

Miscellaneous

Outstanding Shares
14,143,000
Free Float
9,872,000
Market Cap
$97.73 million
Optionable
Optionable
Beta
1.09

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:JYNT) was last updated on 10/15/2026 by MarketBeat.com Staff.
From Our Partners